Yu Nakanishi

Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer

Yu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi et al. · Respiratory Investigation · 2019 · 119 citations

Medicine, Immunology, Oncology +16

Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction

Kazuyoshi Kuwano, Y Nomoto, Ritsuko Kunitake et al. · European Respiratory Journal · 1997 · 84 citations · Full text

Medicine, Molecular Biology, Pathology +17

Albumin–globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer

Yu Nakanishi, Takeshi Masuda, Kakuhiro Yamaguchi et al. · International Journal of Clinical Oncology · 2019 · 34 citations

Medicine, Immunology, Oncology +17

Impaired host defence against <i>Mycobacterium avium</i> in mice with chronic granulomatous disease

Masaki Fujita, Eiji Harada, Takemasa Matsumoto et al. · Clinical & Experimental Immunology · 2010 · 24 citations · Full text

Life Sciences, Immunology, Microbiology +17

IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis

Yu Nakanishi, Yasushi Horimasu, Kakuhiro Yamaguchi et al. · PLoS ONE · 2021 · 21 citations · Full text

Veterinary Medicine, Pathobiology, Pathology +17